Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 384,322,560
  • Shares Outstanding, K 2,406,679
  • Annual Sales, $ 85,159 M
  • Annual Income, $ 35,153 M
  • 60-Month Beta 0.52
  • Price/Sales 4.51
  • Price/Cash Flow 11.73
  • Price/Book 5.39
Trade JNJ with:

Options Overview Details

View History
  • Implied Volatility 20.24% ( -1.28%)
  • Historical Volatility 10.98%
  • IV Percentile 94%
  • IV Rank 77.46%
  • IV High 22.48% on 08/05/24
  • IV Low 12.53% on 05/09/24
  • Put/Call Vol Ratio 0.30
  • Today's Volume 20,972
  • Volume Avg (30-Day) 18,412
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 375,268
  • Open Int (30-Day) 372,023

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 2.19
  • Number of Estimates 7
  • High Estimate 2.35
  • Low Estimate 2.07
  • Prior Year 2.66
  • Growth Rate Est. (year over year) -17.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
158.77 +1.18%
on 10/04/24
168.46 -4.64%
on 09/10/24
-5.96 (-3.58%)
since 09/09/24
3-Month
146.68 +9.52%
on 07/10/24
168.85 -4.86%
on 09/04/24
+13.60 (+9.25%)
since 07/09/24
52-Week
143.13 +12.24%
on 04/18/24
168.85 -4.86%
on 09/04/24
+2.11 (+1.33%)
since 10/09/23

Most Recent Stories

More News
Intuitive Surgical Stock Declines 0.7% in a Month: Is It Losing Steam?

Shares of Intuitive Surgical ISRG have lost 0.7% in the past month compared with the Zacks Medical - Instruments industry’s decline of 3.4% and the broader Zacks Medical sector’s fall of 4.6%. The...

JNJ : 160.65 (+0.60%)
MDT : 88.35 (+0.24%)
ISRG : 490.38 (+2.00%)
1 Vanguard Index Fund Could Turn $500 Per Month Into a $968,400 Portfolio That Pays $16,000 in Annual Dividend Income

Workers with median earnings can build sizable portfolios that pay hefty amounts of passive income in retirement.

MSFT : 417.46 (+0.66%)
AAPL : 229.54 (+1.67%)
AVGO : 185.95 (+2.89%)
MA : 499.95 (+0.72%)
VIG : 198.93 (+1.07%)
JPM : 213.42 (+1.27%)
V : 276.93 (+0.72%)
XOM : 122.09 (+0.04%)
JNJ : 160.65 (+0.60%)
PG : 169.27 (+0.66%)
UNH : 591.22 (+1.66%)
Should Investors Consider High Yield Dividend Stocks?

When selecting dividend-paying stocks, one of the first things that investors look at is, of course, the annual yield.But are high-yield stocks always the best route for income-focused investors? Let’s...

KO : 69.57 (+0.56%)
JNJ : 160.65 (+0.60%)
PG : 169.27 (+0.66%)
Should JNJ Stock Be in Your Portfolio Ahead of Q3 Earnings?

Johnson & Johnson JNJ will report its third-quarter earnings on Oct. 15. The Zacks Consensus Estimate for sales and earnings is pegged at $22.19 billion and $2.19 per share, respectively. The Zacks Consensus...

JNJ : 160.65 (+0.60%)
LLY : 919.74 (+0.66%)
KVUE : 21.53 (-1.46%)
Top 3 Risk-Averse Stocks to Add Stability to Your Portfolio

Risk-averse investors can build a stable portfolio by focusing on established companies with consistent dividends and proven track records of success.

PG : 169.27 (+0.66%)
JNJ : 160.65 (+0.60%)
NEE : 80.58 (+0.10%)
3 Undervalued Dividend Stocks Primed for Growth in 2025

These quality dividend stocks look significantly undervalued which gives you an opportunity to pair a high-yield dividend with strong capital appreciation

CVX : 149.65 (+0.61%)
HES : 138.48 (+0.83%)
JNJ : 160.65 (+0.60%)
PEP : 172.54 (+1.24%)
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer’s and More

NetworkNewsWire Editorial Coverage : Pharmaceutical companies are demonstrating innovation by not only developing new drugs but also exploring combination therapies and repurposing existing drugs to address...

ANVS : 8.05 (-3.36%)
JNJ : 160.65 (+0.60%)
MRK : 110.27 (+1.61%)
NVS : 115.64 (+1.64%)
GSK : 40.24 (+5.84%)
2 Smart Income Stocks to Buy Right Now

These storied companies have a lot to offer different investors.

KO : 69.57 (+0.56%)
JNJ : 160.65 (+0.60%)
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer’s and More

EQNX::TICKER_START (NYSE:ANVS),(NYSE:JNJ),(NYSE:NVS),(NYSE:MRK),(NYSE:GSK) EQNX::TICKER_END

ANVS : 8.05 (-3.36%)
JNJ : 160.65 (+0.60%)
MRK : 110.27 (+1.61%)
NVS : 115.64 (+1.64%)
GSK : 40.24 (+5.84%)
Johnson & Johnson's Q3 2024 Earnings: What to Expect

Johnson & Johnson is all set to announce its third-quarter results this month, and analysts are projecting double-digit earnings decline.

XLV : 153.34 (+1.02%)
$SPX : 5,792.04 (+0.71%)
JNJ : 160.65 (+0.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among...

See More

Key Turning Points

3rd Resistance Point 163.11
2nd Resistance Point 162.16
1st Resistance Point 161.41
Last Price 160.65
1st Support Level 159.70
2nd Support Level 158.75
3rd Support Level 158.00

See More

52-Week High 168.85
Last Price 160.65
Fibonacci 61.8% 159.02
Fibonacci 50% 155.99
Fibonacci 38.2% 152.96
52-Week Low 143.13

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar